Kelsey explains the questionable science behind using ketamine for treatment resistant depression. Spoiler alert: don't trust drugs that sound like miracle cures.

References:

CHAN, L. F., EU, C. L., SOH, S. Y., MANIAM, T., SHAHIDII KADIR, Z., CHONG,
B. T. W., LOO, J. L., SHARIP, S., WONG, V. C. W., LOO, T. H., NG, Y. P., & KAHN, D. A. (2018). Is Ketamine the Future Clozapine for Depression? A Case Series and Literature Review on Maintenance Ketamine in Treatment-resistant Depression With Suicidal Behavior. Journal of Psychiatric Practice, 24(4), 279–291. https://doi.org/10.1097/PRA.0000000000000316
Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M.,
Vermes, D., Flood, P., & Simpson, H. B. (2013). Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology: Official Publication Of The American College Of Neuropsychopharmacology, 38(12), 2475–2483. https://doi.org/10.1038/npp.2013.150
Corriger A, & Pickering G. (2019). Ketamine and depression: a narrative
review. Drug Design, Development and Therapy, 3051.
Chen, J. (2019, March 21). How New Ketamine Drug Helps with Depression. Retrieved from https://www.yalemedicine.org/stories/ketamine-depression/
Meisner, R. C. (2019, May 20). Ketamine for major depression: New tool, new questions. Retrieved from https://www.health.harvard.edu/blog/ketamine-for-major-depression-new-tool-new-questions-2019052216673

Kelsey explains the questionable science behind using ketamine for treatment resistant depression. Spoiler alert: don’t trust drugs that sound like miracle cures.

References:

CHAN, L. F., EU, C. L., SOH, S. Y., MANIAM, T., SHAHIDII KADIR, Z., CHONG,
B. T. W., LOO, J. L., SHARIP, S., WONG, V. C. W., LOO, T. H., NG, Y. P., & KAHN, D. A. (2018). Is Ketamine the Future Clozapine for Depression? A Case Series and Literature Review on Maintenance Ketamine in Treatment-resistant Depression With Suicidal Behavior. Journal of Psychiatric Practice, 24(4), 279–291. https://doi.org/10.1097/PRA.0000000000000316


Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M.,
Vermes, D., Flood, P., & Simpson, H. B. (2013). Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology: Official Publication Of The American College Of Neuropsychopharmacology, 38(12), 2475–2483. https://doi.org/10.1038/npp.2013.150


Corriger A, & Pickering G. (2019). Ketamine and depression: a narrative
review. Drug Design, Development and Therapy, 3051.


Chen, J. (2019, March 21). How New Ketamine Drug Helps with Depression. Retrieved from https://www.yalemedicine.org/stories/ketamine-depression/


Meisner, R. C. (2019, May 20). Ketamine for major depression: New tool, new questions. Retrieved from https://www.health.harvard.edu/blog/ketamine-for-major-depression-new-tool-new-questions-2019052216673